| WETO | PRESS-RELEASE | neutral | 2/10 | Wetour Robotics issued a press release with no material financial or operational details disclosed. The announcement app | Oct 15, 2026 |
| CAT | PRESS-RELEASE | neutral | 1/10 | Caterpillar Inc. announced it will report its Q3 2026 results on October 29. | Oct 15, 2026 |
| NVMI | PRESS-RELEASE | neutral | 1/10 | NOVA announced it will report its Q3 2026 results on November 5. | Oct 15, 2026 |
| CGNX | PRESS-RELEASE | neutral | 1/10 | Cognex Corporation announced it will report its Q3 2026 results on November 4, 2026. | Oct 15, 2026 |
| ALL | PRESS-RELEASE | neutral | 3/10 | Allstate reported September 2026 catastrophe losses of $220M pre-tax ($173M after-tax), bringing Q3 2026 total catastrop | Oct 15, 2026 |
| MDA | PRESS-RELEASE | neutral | 1/10 | MDA Space announced it will host a conference call on November 5, 2026 to discuss its Q3 2026 results. | Oct 15, 2026 |
| GILT | PRESS-RELEASE | neutral | 1/10 | Gilat Satellite Networks Ltd. announced it will report its Q3 2026 results on November 10. | Oct 15, 2026 |
| LH | PRESS-RELEASE | bullish | 6/10 | Labcorp agreed to acquire select assets of BioReference Health from OPKO Health for $722M in cash at closing, plus up to | Oct 15, 2026 |
| HELP | PRESS-RELEASE | neutral | 3/10 | Helus Pharma appointed Dr. Suresh Durgam, a CNS drug-development executive with FDA approval experience (CAPLYTA), to it | Oct 15, 2026 |
| ATCH | PRESS-RELEASE | bullish | 6/10 | AtlasClear announced a definitive agreement to acquire Ark Financial Services (parent of Dawson James Securities) for up | Oct 15, 2026 |
| PVLA | PRESS-RELEASE | neutral | 4/10 | Palvella Therapeutics announced poster presentations at the PeDRA Annual Conference featuring new pediatric analyses fro | Oct 15, 2026 |
| CXT | PRESS-RELEASE | neutral | 1/10 | Crane NXT announced it will report its Q3 2026 results. | Oct 15, 2026 |
| EVCM | PRESS-RELEASE | neutral | 1/10 | EverCommerce Inc. announced it will report its Q3 2026 results. | Oct 15, 2026 |
| SPRC | PRESS-RELEASE | neutral | 3/10 | SciSparc announced a strategic shift toward Agentic AI-powered technologies, including cybersecurity and finance, while | Oct 15, 2026 |
| FA | PRESS-RELEASE | neutral | 1/10 | First Advantage Corporation announced it will report its Q3 2026 results on November 5, 2026. | Oct 15, 2026 |
| PLUG | PRESS-RELEASE | neutral | 1/10 | Plug Power, Inc. announced it will report its Q3 2026 results on November 9. | Oct 15, 2026 |
| LGND | PRESS-RELEASE | neutral | 1/10 | Ligand Pharmaceuticals announced it will report its Q3 2026 results on October 29, 2026. | Oct 15, 2026 |
| JG | PRESS-RELEASE | neutral | 3/10 | Aurora Mobile's GPTBots.ai platform partnered with AI Storm Co., Ltd. (Tokyo: 3719) to deploy a Human-Led AI initiative | Oct 15, 2026 |
| ADMA | PRESS-RELEASE | neutral | 4/10 | ADMA Biologics announced a peer-reviewed publication in Frontiers in Cardiovascular Medicine detailing data from its opt | Oct 15, 2026 |
| CLRB | PRESS-RELEASE | bullish | 6/10 | Cellectar Biosciences reported positive subgroup data from its Phase 2b CLOVER WaM trial of iopofosine I 131 in Waldenst | Oct 15, 2026 |
| ANL | PRESS-RELEASE | neutral | 4/10 | Adlai Nortye announced clinical trial collaboration and supply agreements with Eli Lilly and Merck KGaA for cetuximab, t | Oct 15, 2026 |
| AQST | PRESS-RELEASE | bullish | 7/10 | Aquestive Therapeutics announced FDA acceptance of its resubmitted NDA for Anaphylm (dibutepinephrine) sublingual film a | Oct 15, 2026 |
| CRON | PRESS-RELEASE | bullish | 6/10 | Cronos Group completed its acquisition of CanAdelaar, the largest cannabis company in the Netherlands' adult-use pilot p | Oct 15, 2026 |
| GOGO | PRESS-RELEASE | bullish | 6/10 | Gogo announced that PlaneSense, a leading fractional aircraft ownership company, will equip its entire fleet of 71 Pilat | Oct 15, 2026 |
| MED | PRESS-RELEASE | neutral | 2/10 | Medifast issued a press release debunking menopause weight gain myths and promoting its Trilivy metabolic health system, | Oct 15, 2026 |
| IMCR | PRESS-RELEASE | neutral | 4/10 | Immunocore dosed the first patient in a Phase 1 trial of IMC-S118AI, its first tissue-specific autoimmune candidate for | Oct 15, 2026 |
| SGI | PRESS-RELEASE | neutral | 1/10 | Somnigroup International announced it will report its Q3 2026 results on November 9, 2026. | Oct 15, 2026 |
| DTM | PRESS-RELEASE | neutral | 1/10 | DT Midstream, Inc. announced it will report its Q3 2026 results. | Oct 15, 2026 |
| PAG | PRESS-RELEASE | neutral | 2/10 | Penske Automotive Group increased its quarterly dividend by $0.02 to $1.46 per share, a 1.4% sequential increase, bringi | Oct 15, 2026 |
| BNY | PRESS-RELEASE | bullish | 6/10 | BNY reported Q3 2026 adjusted EPS of $2.37, beating consensus of $2.26 by 4.8%. Revenue of $5.676B grew 12% YoY, driven | Oct 15, 2026 |
